201 related articles for article (PubMed ID: 29214340)
1. Management and outcomes of treating pediatric medulloblastoma: an eight years' experience in an Iranian pediatric center.
Mehrvar A; Tashvighi M; Hedayati Asl AA; Niktoreh-Mofrad N; Mehrvar N; Afsar N; Naderi A; Allebouyeh M; Qaddoumi I; Faranoush M
Childs Nerv Syst; 2018 Apr; 34(4):639-647. PubMed ID: 29214340
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and abandonment and outcome of treatment in 67 Chinese children with medulloblastoma.
Wang C; Yuan XJ; Jiang MW; Wang LF
J Neurosurg Pediatr; 2016 Jan; 17(1):49-56. PubMed ID: 26451721
[TBL] [Abstract][Full Text] [Related]
3. Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse.
Herrlinger U; Steinbrecher A; Rieger J; Hau P; Kortmann RD; Meyermann R; Schabet M; Bamberg M; Dichgans J; Bogdahn U; Weller M
J Neurol; 2005 Mar; 252(3):291-9. PubMed ID: 16189725
[TBL] [Abstract][Full Text] [Related]
4. Management and treatment of children with medulloblastoma in Serbia, a middle-income country.
Bokun J; Grujicic D; Skender-Gazibara M; Paripovic L; Pekmezovic T; Kisic-Tepavcevic D; Ilic V; Raicevic S; Stanic D; Miskovic I; Saric M; Nikitovic M
J BUON; 2018; 23(4):1156-1162. PubMed ID: 30358225
[TBL] [Abstract][Full Text] [Related]
5. [Medulloblastoma in adults].
Hopf-Jensen S; Buchalla R; Preiß M; Feist H; Börm W; Müller-Hülsbeck S
Rofo; 2014 Sep; 186(9):825-8. PubMed ID: 25171381
[No Abstract] [Full Text] [Related]
6. Demographics, patterns of care, and survival in pediatric medulloblastoma.
Dressler EV; Dolecek TA; Liu M; Villano JL
J Neurooncol; 2017 May; 132(3):497-506. PubMed ID: 28290003
[TBL] [Abstract][Full Text] [Related]
7. Improving the quality of care in the molecular era for children and adolescents with medulloblastoma.
de Rojas T; Puertas M; Bautista F; de Prada I; López-Pino MÁ; Rivero B; Gonzalez-San Segundo C; Gonzalez-Vicent M; Lassaletta A; Madero L; Moreno L
Clin Transl Oncol; 2019 Dec; 21(12):1687-1698. PubMed ID: 30937816
[TBL] [Abstract][Full Text] [Related]
8. Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea.
Yoon JH; Park KD; Kang HJ; Kim H; Lee JW; Kim SK; Wang KC; Park SH; Kim IH; Shin HY
World J Pediatr; 2017 Aug; 13(4):367-373. PubMed ID: 28550392
[TBL] [Abstract][Full Text] [Related]
9. Twenty years experience in treating childhood medulloblastoma: Between the past and the present.
Khalil J; Qing Z; Chuanying Z; Belkacémi Y; Benjaafar N; Mawei J
Cancer Radiother; 2019 Jun; 23(3):179-187. PubMed ID: 31109839
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting survival of medulloblastoma in children: the changing concept of management.
Wong TT; Liu YL; Ho DM; Chang KP; Liang ML; Chen HH; Lee YY; Chang FC; Lin SC; Hsu TR; Chen KW; Kwang WK; Hou WY; Wang CY; Yen SH; Guo WY; Chen YW
Childs Nerv Syst; 2015 Oct; 31(10):1687-98. PubMed ID: 26351222
[TBL] [Abstract][Full Text] [Related]
11. Medulloblastoma: recent advances and directions in diagnosis and management--Part I.
Chin HW; Maruyama Y; Young AB
Curr Probl Cancer; 1984 May; 8(11):4-54. PubMed ID: 6383718
[No Abstract] [Full Text] [Related]
12. Updates on Management of Adult Medulloblastoma.
Majd N; Penas-Prado M
Curr Treat Options Oncol; 2019 Jun; 20(8):64. PubMed ID: 31236711
[TBL] [Abstract][Full Text] [Related]
13. Medulloblastoma with melanotic differentiation: case report and review of the literature.
Phillips CL; Miles L; Jones BV; Sutton M; Crone K; Fouladi M
J Neurooncol; 2011 Jul; 103(3):759-64. PubMed ID: 20953660
[TBL] [Abstract][Full Text] [Related]
14. Medulloblastoma.
Padovani L; André N; Gentet JC; Muracciole X
Eur J Cancer; 2011 Sep; 47 Suppl 3():S338. PubMed ID: 21944006
[No Abstract] [Full Text] [Related]
15. Local control in non-metastatic medulloblastoma.
Christopherson KM; Bradley JA; Rotondo RL; Pincus DW; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
Acta Oncol; 2014 Sep; 53(9):1151-7. PubMed ID: 24991891
[TBL] [Abstract][Full Text] [Related]
16. Shedding light on adult medulloblastoma: current management and opportunities for advances.
Brandes AA; Franceschi E
Am Soc Clin Oncol Educ Book; 2014; ():e82-7. PubMed ID: 24857151
[TBL] [Abstract][Full Text] [Related]
17. Management of pediatric and adult patients with medulloblastoma.
Martin AM; Raabe E; Eberhart C; Cohen KJ
Curr Treat Options Oncol; 2014 Dec; 15(4):581-94. PubMed ID: 25194927
[TBL] [Abstract][Full Text] [Related]
18. Management and Long-term Outcomes of Adults With Medulloblastoma: A Single-Center Experience.
Neth BJ; Raghunathan A; Kizilbash SH; Uhm JH; Breen WG; Johnson DR; Daniels DJ; Sener U; Carabenciov ID; Campian JL; Khatua S; Mahajan A; Ruff MW
Neurology; 2023 Sep; 101(12):e1256-e1271. PubMed ID: 37524533
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological characteristics and survival outcomes of children with medulloblastoma treated at the National Cancer Institute (INCA) in Rio de Janeiro, Brazil.
Oigman G; Osorio DS; Ferman S; Stanek JR; Aversa do Souto A; Christiani MMC; Magalhaes DMA; Finlay JL; Vianna DA
Pediatr Blood Cancer; 2022 Jan; 69(1):e29274. PubMed ID: 34767315
[TBL] [Abstract][Full Text] [Related]
20. SIOP PODC adapted treatment recommendations for standard-risk medulloblastoma in low and middle income settings.
Parkes J; Hendricks M; Ssenyonga P; Mugamba J; Molyneux E; Schouten-van Meeteren A; Qaddoumi I; Fieggen G; Luna-Fineman S; Howard S; Mitra D; Bouffet E; Davidson A; Bailey S;
Pediatr Blood Cancer; 2015 Apr; 62(4):553-64. PubMed ID: 25418957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
